Status: Automated market-move research draft
SAGILITY • NSE • F&O Stock
SAGILITY LIMITED traded at ₹42.54, -2.09% versus the previous close of ₹43.45. Latest market data: 29 Sep 2026 • 03:15 PM IST.
- The stock is -2.09% at ₹42.54.
- Likely reason: Profit-taking and technical weakness extending recent downward trend
- Approximate traded value is ₹47.90 crore.
- It is -26.52% from its 52-week high and +18.73% from its 52-week low.
- The stock is being compared with Nifty Pharma alongside the Nifty 50.
SAGILITY LIMITED Share Price Today – Market Snapshot
Why Is SAGILITY LIMITED Share Price Falling Today?
Sagility Limited shares experienced a downward pull in today's trading session, declining 2.09% to close at ₹42.54. The stock opened near the previous day's close at ₹43.32 and drifted lower, touching an intraday low of ₹42.12 before finding some stabilization. Trading volumes came in moderately higher than recent averages, with total volume standing roughly 23% above its 5-day norm, pointing to active selling pressure during the session.
While the broader market benchmark Nifty saw a mild negative drift of 0.28%, Sagility underperformed its broader indices, though it contrasted with the Nifty Pharma sector index, which gained 0.64%. The stock's short-term trajectory reflects ongoing downward momentum, with 5-day and 20-day returns standing at -6.73% and -8.42% respectively, extending the corrective phase from its 52-week high of ₹57.89.
Although no major company-specific announcement or earnings release was published today to trigger the drop, the stock continues to digest recent corporate updates, including shareholder distributions regarding the final dividend for FY2025-26 and regular investor meet engagements. The price movement appears technical and sentiment-driven in the absence of fresh fundamental catalysts, with participants reacting to broader consolidation in mid-cap IT-enabled and BPM spaces.
low confidence
- Stock declined 2.09% with volume 23% higher than the 5-day average.
- Negative short-term momentum reflected in 5-day (-6.73%) and 20-day (-8.42%) returns.
- Absence of any same-day fundamental catalyst or corporate announcement.
Performance Context
Cash-Market Activity
| Today’s Volume | 11,260,598 |
|---|---|
| 5-Day Avg. Volume | 9,160,908 |
| 20-Day Avg. Volume | 12,393,963 |
| Volume vs 20-Day Avg. | 0.91x |
| Delivery Quantity | 5,089,888 |
| Delivery % | 44.78% |
| Number of Trades | 28,044 |
Derivative-Market Activity
| Near-Month Futures | ₹43.44 |
|---|---|
| Cash Reference | ₹43.44 |
| Premium / Discount | ₹0.00 (+0.00%) |
| Change in Premium | ₹0.01 |
| Futures Volume | 2,301 |
| Volume vs Previous Session | 0.66x |
| Open Interest | 13,848,000 |
| OI vs Previous Session | 0.37x |
Ownership & Transaction Activity
Promoter Pledge / Encumbrance
The promoter/promoter-group disclosure states that the shares covered by the filing were free from encumbrance.
Source: NSE corporate filing
Recent Ownership / Shareholding Disclosure
- Sagility B.V. confirmed via regulatory filing that no new encumbrances or pledges were created on promoter shareholdings during the period ending March 31, 2026.
Source: NSE corporate disclosure. Only factual ownership/shareholding details extracted from the filing are shown.
WittyTrades Data Insight
Price Position: The stock is around the middle of the day’s trading range.
Move From Open: -1.80%.
Intraday Range: 2.76% of the previous close.
5-Day Performance: -6.73%; 20-Day Performance: -8.42%.
Latest Company Developments
Relative Performance
| SAGILITY LIMITED | -2.09% |
|---|---|
| Nifty 50 | -0.28% |
| Nifty Pharma | +0.64% |
| Vs Nifty 50 | -1.81% |
| Vs Sector | -2.73% |
Technical Context
| Price | ₹42.54 |
|---|---|
| Day High / Low | ₹43.32 / ₹42.12 |
| 52-Week High | ₹57.89 |
| 52-Week Low | ₹35.83 |
| 5-Day Return | -6.73% |
| 20-Day Return | -8.42% |
What Should Traders and Investors Watch Next?
- Volume and delivery trends around the ₹42 support zone to gauge selling exhaustion.
- Open interest shifts and futures unwinding following significant OI reduction in recent sessions.
- Upcoming institutional investor interactions and management commentary on healthcare BPM demand.
- Broader movement in mid-cap IT-enabled and specialized healthcare services benchmarks.
Catalyst note: No single confirmed fundamental trigger was identified; the move reflects technical selling and continuation of recent short-term weakness.
Frequently Asked Questions
What is the likely reason for today’s move?
With no fresh negative fundamental news or earnings triggers released today, the 2.09% decline accompanied by above-average volume appears driven by continuation of recent selling pressure and technical weakness following prior sessions' negative returns.
Is trading volume elevated?
Today’s volume is 11,260,598. The latest 20-day average available is 12,393,963, equivalent to about 0.91x of the recent average.
What does the derivatives market show?
The latest official NSE F&O report is summarised in the Derivative-Market Activity box above.
Before acting on this stock
Consult your own investment adviser before acting on any security. If you are interested in stock research or other available research categories, review the WittyTrades subscription plans and research segments.
Market data, exchange filings, company disclosures and reputable business-media reports are collected automatically and summarised for investor context. Material facts are cross-checked where possible; price data may be delayed and a cited development should not be assumed to be the sole cause of a market move unless the evidence supports that conclusion.
Article by: WittyTrades Research Desk
Investments in securities markets are subject to market risks. Read all related documents carefully before investing.
Registration granted by SEBI, membership of a supervisory body and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors.
This article is intended for informational and educational purposes and should not be treated as personalised investment advice or a recommendation to buy, sell or hold any security.
Market data may be delayed and readers should independently verify current prices and disclosures before taking investment decisions.